GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 78 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $47,000 | -2.1% | 21,677 | +0.3% | 0.00% | – |
| Q4 2020 | $48,000 | -18.6% | 21,619 | -2.8% | 0.00% | – |
| Q3 2020 | $59,000 | -15.7% | 22,241 | -2.2% | 0.00% | – |
| Q2 2020 | $70,000 | +52.2% | 22,746 | -4.1% | 0.00% | – |
| Q1 2020 | $46,000 | -36.1% | 23,712 | -5.5% | 0.00% | – |
| Q4 2019 | $72,000 | -22.6% | 25,082 | -0.8% | 0.00% | – |
| Q3 2019 | $93,000 | +9.4% | 25,294 | +23.3% | 0.00% | – |
| Q2 2019 | $85,000 | -100.0% | 20,506 | -94.1% | 0.00% | -100.0% |
| Q1 2016 | $500,000,000 | +12.9% | 349,425 | +29.5% | 0.00% | 0.0% |
| Q4 2015 | $443,000,000 | +79433.2% | 269,925 | +13.4% | 0.00% | 0.0% |
| Q3 2015 | $557,000 | -99.9% | 237,925 | +22.9% | 0.00% | 0.0% |
| Q2 2015 | $528,596,000 | -9.4% | 193,625 | +11.2% | 0.00% | 0.0% |
| Q1 2015 | $583,241,000 | +1263.5% | 174,102 | +1312.4% | 0.00% | – |
| Q4 2014 | $42,775,000 | -27.8% | 12,327 | +4.7% | 0.00% | – |
| Q3 2014 | $59,228,000 | -63.6% | 11,775 | -0.1% | 0.00% | -100.0% |
| Q2 2014 | $162,737,000 | – | 11,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 89,240 | $255,000 | 0.09% |
| BT Wealth Management LLC | 57,009 | $163,000 | 0.08% |
| HighVista Strategies LLC | 30,200 | $86,000 | 0.06% |
| D.A. DAVIDSON & CO. | 840,948 | $2,405,000 | 0.04% |
| Iron Gate Global Advisors LLC | 17,090 | $49,000 | 0.03% |
| Advisor Group, Inc. | 799,846 | $2,287,000 | 0.02% |
| Virtu Financial LLC | 54,738 | $157,000 | 0.02% |
| JOYN Advisors, Inc. | 12,796 | $37,000 | 0.01% |
| Vivaldi Capital Management LP | 10,668 | $31,000 | 0.01% |
| Ameritas Investment Company, LLC | 10,782 | $31,000 | 0.01% |